Detalhe da pesquisa
1.
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.
Cell
; 167(5): 1281-1295.e18, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27863244
2.
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study.
Br J Haematol
; 201(6): 1116-1124, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004981
3.
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
Br J Haematol
; 200(2): 175-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214090
4.
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML.
Blood
; 137(24): 3390-3402, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33690800
5.
Sensitisation of cancer cells to radiotherapy by serine and glycine starvation.
Br J Cancer
; 127(10): 1773-1786, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115879
6.
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial.
Haematologica
; 107(12): 2859-2869, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615931
7.
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients.
Br J Haematol
; 194(2): 393-402, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34195988
8.
Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancer.
Int J Colorectal Dis
; 36(12): 2603-2611, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296325
9.
Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta-analysis of studies over the last ten years.
Br J Haematol
; 189(3): 452-468, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072631
10.
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL.
Blood
; 132(23): 2446-2455, 2018 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30287523
11.
Novel analytical methods to interpret large sequencing data from small sample sizes.
Hum Genomics
; 13(1): 41, 2019 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31470908
12.
PAF promotes stemness and radioresistance of glioma stem cells.
Proc Natl Acad Sci U S A
; 114(43): E9086-E9095, 2017 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29073105
13.
Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice.
Br J Haematol
; 187(5): 615-626, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394591
14.
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients.
Br J Haematol
; 204(4): 1536-1539, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38323384
15.
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.
Blood
; 129(7): 846-854, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932374
16.
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.
Haematologica
; 104(6): 1150-1155, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573507
17.
Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line.
Ann Hematol
; 98(5): 1159-1168, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30798348
18.
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group.
Cancer
; 124(14): 2956-2963, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29723417
19.
Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study.
Cancer
; 123(10): 1791-1799, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28026860
20.
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.
Cancer
; 123(22): 4403-4410, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28743166